General Information of Drug (ID: DM4JG0B)

Drug Name
DA-3607 Drug Info
Synonyms Ad-stTRAIL; TRAIL adenoviral gene therapy (cancer), Dong-A
Indication
Disease Entry ICD 11 Status REF
Brain cancer 2A00 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM4JG0B

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ad5-TRAIL DM2UMGE Prostate cancer 2C82.0 Phase 1 [3]
ABBV-621 DM90EO3 Haematological malignancy 2B33.Y Phase 1 [4]
Nimesulide DMR1NMD Metastatic colorectal cancer 2B91 Terminated [5]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
TNF related apoptosis inducing ligand (TNFSF10) TTA5MS9 TNF10_HUMAN Binder [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026657)
2 Cancer gene therapy using a novel secretable trimeric TRAIL. Gene Ther. 2006 Feb;13(4):330-8.
3 Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors. Cancer Gene Ther. 2006 Jun;13(6):628-32.
4 Clinical pipeline report, company report or official report of AbbVie.
5 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.